- Home
- SNY vs JCI Comparison
SNY vs JCI Comparison
Compare SNY & JCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNY | JCI |
|---|---|---|
| Founded | 1994 | 1885 |
| Country | France | Ireland |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5B | 86.2B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | SNY | JCI |
|---|---|---|
| Price | $42.87 | $154.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $58.00 | ★ $134.60 |
| AVG Volume (30 Days) | 3.1M | ★ 3.4M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.47% | 1.13% |
| EPS Growth | N/A | ★ 99.60 |
| EPS | N/A | ★ 1.86 |
| Revenue | N/A | ★ $9,902,000,000.00 |
| Revenue This Year | $3.49 | $7.61 |
| Revenue Next Year | $6.10 | $6.57 |
| P/E Ratio | ★ $6.14 | $82.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.89 | $103.07 |
| 52 Week High | $52.68 | $157.06 |
Technical Indicators
Market Signals| Indicator | SNY | JCI |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 67.90 |
| Support Level | $42.64 | $136.56 |
| Resistance Level | $43.48 | N/A |
| Average True Range (ATR) | 0.71 | 4.48 |
| MACD | -0.12 | 1.41 |
| Stochastic Oscillator | 45.47 | 86.02 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About JCI Johnson Controls International plc
Following Johnson Controls' divestiture of its residential and light commercial HVAC businesses to Bosch in 2025, nearly all of its revenue comes from commercial HVAC (60%) and fire and security products and services (40%). A 2016 merger joined Johnson Controls' HVAC and Tyco's fire and security businesses with the premise that there is synergy in offering a broader variety of automation products and solutions to commercial buildings. We estimate Johnson Controls' pro forma revenue mix will be one-third products, one-third installation, and one-third services.